Jiangsu Historical Cash Flow

688399 Stock   70.20  0.17  0.24%   
Analysis of Jiangsu Bioperfectus cash flow over time is an excellent tool to project Jiangsu Bioperfectus future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Investments of 485.5 M or Change In Cash of 212.9 M as it is a great indicator of Jiangsu Bioperfectus ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Jiangsu Bioperfectus latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Jiangsu Bioperfectus is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu Bioperfectus Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Jiangsu Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Jiangsu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Jiangsu's non-liquid assets can be easily converted into cash.

Jiangsu Bioperfectus Cash Flow Chart

At present, Jiangsu Bioperfectus' Change To Inventory is projected to decrease significantly based on the last few years of reporting. The current year's Investments is expected to grow to about 485.5 M, whereas Change In Cash is forecasted to decline to about 212.9 M.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Jiangsu Bioperfectus to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Jiangsu Bioperfectus operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Total Cashflows From Investing Activities

The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.
Most accounts from Jiangsu Bioperfectus' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Jiangsu Bioperfectus current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu Bioperfectus Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Jiangsu Bioperfectus' Change To Inventory is projected to decrease significantly based on the last few years of reporting. The current year's Investments is expected to grow to about 485.5 M, whereas Change In Cash is forecasted to decline to about 212.9 M.
 2021 2022 2023 2024 (projected)
Dividends Paid325.4M590.6M6.0M5.7M
Depreciation40.8M94.0M78.9M82.9M

Jiangsu Bioperfectus cash flow statement Correlations

0.54-0.62-0.3-0.7-0.96-0.190.06-0.980.510.00.030.320.01-0.03-0.28
0.540.180.36-0.2-0.610.53-0.53-0.530.220.580.62-0.380.540.570.53
-0.620.180.760.650.50.76-0.680.61-0.370.560.58-0.780.530.650.86
-0.30.360.760.760.350.96-0.870.4-0.720.910.91-0.990.840.940.91
-0.7-0.20.650.760.80.64-0.410.77-0.870.580.53-0.740.350.50.58
-0.96-0.610.50.350.80.18-0.040.98-0.690.050.0-0.340.00.040.2
-0.190.530.760.960.640.18-0.840.24-0.540.960.97-0.970.810.930.96
0.06-0.53-0.68-0.87-0.41-0.04-0.84-0.170.44-0.78-0.830.88-0.96-0.97-0.86
-0.98-0.530.610.40.770.980.24-0.17-0.640.070.04-0.410.110.130.31
0.510.22-0.37-0.72-0.87-0.69-0.540.44-0.64-0.56-0.510.69-0.49-0.52-0.41
0.00.580.560.910.580.050.96-0.780.07-0.560.99-0.920.790.910.86
0.030.620.580.910.530.00.97-0.830.04-0.510.99-0.920.840.940.88
0.32-0.38-0.78-0.99-0.74-0.34-0.970.88-0.410.69-0.92-0.92-0.85-0.94-0.93
0.010.540.530.840.350.00.81-0.960.11-0.490.790.84-0.850.950.79
-0.030.570.650.940.50.040.93-0.970.13-0.520.910.94-0.940.950.9
-0.280.530.860.910.580.20.96-0.860.31-0.410.860.88-0.930.790.9
Click cells to compare fundamentals

Jiangsu Bioperfectus Account Relationship Matchups

Jiangsu Bioperfectus cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory(5.0M)(144.7M)(91.1M)(186.3M)34.0M35.7M
Investments(550M)(133.5M)(450.4M)(470.2M)462.3M485.5M
Change In Cash65.2M548.8M1.4M580.3M403.2M212.9M
Depreciation17.4M22.1M40.8M94.0M78.9M82.9M
Capital Expenditures105.8M134.6M303.6M350.7M111.3M159.1M
Total Cash From Operating Activities106.7M935.9M985.5M2.0B(113.1M)(107.5M)
Net Income83.8M819.6M1.2B1.8B(384.4M)(365.2M)
End Period Cash Flow97.4M646.1M647.5M1.2B1.6B1.7B
Free Cash Flow944.3K801.3M681.9M1.6B(224.5M)(213.3M)
Change In Working Capital5.7M105.8M(249.2M)(327.8M)(67.8M)(71.2M)
Begin Period Cash Flow32.1M97.4M646.1M647.5M1.2B1.3B
Total Cashflows From Investing Activities(654.4M)(259.6M)(748.6M)(717.9M)(646.1M)(678.4M)
Other Non Cash Items3.3M4.8M16.1M21.6M40.0M42.0M
Change To Account Receivables(20.7M)(166.4M)(253.9M)(660.4M)(594.3M)(564.6M)
Change To Netincome448.5K(16.1M)(10.6M)353.7M406.8M427.1M
Change To Liabilities27.9M416.9M95.8M518.9M596.7M626.6M

Currently Active Assets on Macroaxis

Other Information on Investing in Jiangsu Stock

The Cash Flow Statement is a financial statement that shows how changes in Jiangsu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Jiangsu's non-liquid assets can be easily converted into cash.